XGN - Exagen prices public offering of common stock May, 08 2025 08:56 AM Exagen Inc. 2025-05-08 08:56:45 ET More on Exagen Exagen: Buy An Undervalued Diagnostics Developer That Is On The Path To Profitability Exagen Inc. anticipates $65M revenue for 2025 amid ASP growth and new biomarker launches Exagen announces senior secured credit facility For further details see: Exagen prices public offering of common stock